Profit of Doom?

Sullivan, Andrew
March 2001
New Republic;03/26/2001, Vol. 224 Issue 13, p6
Defends pharmaceutical companies in the United States against criticism that they are not doing enough to fight the worldwide AIDS epidemic. The benefits of the U.S. free-market system, in promoting research on anti-AIDS drugs; Comparison to drug-research decline in Europe and India, due to state regulation; Generosity of U.S. drug makers to sell anti-retroviral in developing world at fraction of Western market prices; The author's criticism of Western and African governments' lack of action regarding the AIDS crisis.


Related Articles

  • Bitter Pill.  // Latin Trade (English);Jul2007, Vol. 15 Issue 7, p13 

    The article reports that Brazil has taken huge strides in bringing its HIV/AIDs crisis under control, including forcing foreign drug makers to lower prices. For the first time, however, it broke a patent outright, on efavirenz, a Merck antiretroviral drug used in combination with other drugs to...

  • New hope.  // Finweek;11/30/2006, p63 

    The article reports on the initiatives of the government of South Africa to prevent and control the spread of AIDS in the region. The government initially launched the Treatment Action Campaign and another AIDS plan would be launched on World AIDS Day. More antiretroviral drugs will also be...

  • Counterpoint: HIV/AIDS Drug Subsidies Are Ineffective. Rich, Alex K.; Konczal, Ed // Points of View: Subsidizing HIV/AIDS Drugs;3/1/2016, p3 

    The article presents an argument that spending funds on the distribution of antiretroviral drugs for AIDS patients is futile due to the complexity of the human immunodeficiency virus (HIV). It is asserted that providing subsidies for expensive AIDS drugs will not be enough to be able to reach...

  • Social Disease. Beinart, Peter // New Republic;1/21/2002, Vol. 226 Issue 2, p6 

    Offers observations on the policies of South African president Thabo Mbeki on AIDS. Communist influence in South African political history; Differences between international and domestic opinion of Mbeki; Explication of his Afrocentric views on AIDS; Suggestion that he is taking the wrong...

  • HIV Chemoprophylaxis: New optimism and new challenges. Mayer, Kenneth // Bay Windows;12/2/2010, Vol. 28 Issue 51, p1 

    The article focuses on the findings of a research published in the "New England Journal of Medicine" which stated that taking a daily antiretroviral pill can protect HIV-uninfected men who have sexual relations with men from becoming infected.

  • Mitochondrial Disorders among Infants Exposed to HIV and Antiretroviral Therapy. Funk, Michele Jonsson; Belinson, Suzanne E.; Pimenta, Jeanne M.; Morsheimer, Megan; Gibbons, David C. // Drug Safety;2007, Vol. 30 Issue 10, p845 

    Although antiretroviral therapy (ART) is critical for preventing mother-to-child transmission of HIV, concern has been raised about the possibility that it may cause mitochondrial dysfunction in infants. There is adequate evidence for a mechanism by which exposure to nucleoside reverse...

  • Antiretroviral price reductions possible.  // PharmacoEconomics & Outcomes News;10/21/2006, Issue 514, p7 

    The article reveals that price reductions for some antiretrovirals, purchased by developing countries, is possible according to a study conducted by multinational researchers. Price decreases will depend on future costs of active pharmaceutical ingredients, but could be realized if indirect cost...

  • South Africa's AIDS policy caused 365,000 deaths.  // Contemporary Sexuality;Jan2009, Vol. 43 Issue 1, p7 

    The article reports that 365,000 South Africans may have died from AIDS complications as a result of South Africa's policy towards HIV and AIDS according to a Harvard University study published in the December 2008 issue of the "Journal of Acquired Immune Deficiency Syndrome." The article was...

  • Policy & Price. Gopal, Kevin // Pharmaceutical Executive;Aug99, Vol. 19 Issue 8, p30 

    Focuses on the renegotiation of the Pharmaceutical Price Regulation Scheme (PPRS) between the British government and the pharmaceutical industry. Price reduction of branded medicines; Measures that offset the price reduction in the PPRS; How the PPRS gave the government an economic opportunity.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics